The Endometrial Microbiome and Reproductive Outcomes Following Assisted Reproductive Technologies: A Systematic Review
Journal of Reproductive Immunology · 2026-11 · 105169
DOI: 10.1016/j.jri.2026.105169 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Reproductive Immunology, 2026-11. Verfasst von Ana Maria Mihoci und 7 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The endometrial microbiome has emerged as a potential determinant of endometrial receptivity and reproductive outcomes following assisted reproductive technologies (ART), although its clinical significance remains uncertain. This systematic review evaluated the association between endometrial microbiome composition and reproductive outcomes after ART and critically appraised the evidence supporting microbiome-guided diagnostic and therapeutic strategies. The review was registered in PROSPERO (CRD420261405558) and reported in accordance with the PRISMA 2020 statement. PubMed/MEDLINE, Embase, Scopus, Web of Science Core Collection, and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched from inception to March 2026. Twelve studies involving more than 2200 women undergoing ART met the inclusion criteria. Across the included studies, Lactobacillus-enriched endometrial microbial profiles were associated with more favorable reproductive outcomes in some cohorts; however, findings were inconsistent across studies and individual endpoints, including implantation, clinical pregnancy, ongoing pregnancy, and live birth. Associations involving non-Lactobacillus microbial profiles were also heterogeneous and should be interpreted in the context of study-specific microbial definitions and patient populations. Preliminary non-randomized studies have reported favorable reproductive outcomes following microbiome-guided management in selected populations, but these findings do not establish treatment efficacy. However, substantial heterogeneity in study populations, microbiome assessment methods, definitions of dysbiosis, and outcome reporting limits the certainty and clinical applicability of the available evidence. Overall, current evidence supports a biologically plausible association between endometrial microbiome composition and reproductive outcomes following ART, but well-designed prospective studies using standardized methodologies are needed to determine whether endometrial microbial signatures can serve as clinically actionable biomarkers and therapeutic targets.
Zitieren
APA
Mihoci, A. M., Socolov, D., Dumitrescu, R. D., Nemescu, D., Mihoci, E. C., Voicu, I., Scripcariu, I., & Socolov, R. V. (2026). The Endometrial Microbiome and Reproductive Outcomes Following Assisted Reproductive Technologies: A Systematic Review. Journal of Reproductive Immunology, 105169. https://doi.org/10.1016/j.jri.2026.105169
Vancouver
Mihoci AM, Socolov D, Dumitrescu RD, Nemescu D, Mihoci EC, Voicu I, et al. The Endometrial Microbiome and Reproductive Outcomes Following Assisted Reproductive Technologies: A Systematic Review. Journal of Reproductive Immunology. 2026:105169. doi:10.1016/j.jri.2026.105169
BibTeX
@article{Mihoci2026,
author = {Mihoci, Ana Maria and Socolov, Demetra and Dumitrescu, Ruxandra Daniela and Nemescu, Dragos and Mihoci, Eduard Cristian and Voicu, Irina and Scripcariu, Ioana-Sadyie and Socolov, Razvan Vladimir},
title = {The Endometrial Microbiome and Reproductive Outcomes Following Assisted Reproductive Technologies: A Systematic Review},
journal = {Journal of Reproductive Immunology},
year = {2026},
pages = {105169},
doi = {10.1016/j.jri.2026.105169}
}
EUVIMED